Medicenna Therapeutics Corp. (MDNA) Social Stream



Medicenna Therapeutics Corp. (MDNA): $1.15

-0.03 (-2.54%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add MDNA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 496

in industry

Medicenna Therapeutics Corp (MDNA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MDNA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-16 4 $12 $7 $10.018 $1.3 670.62%
2022-02-10 5 $12 $7 $9.685 $1.3 645%
2022-03-15 5 $12 $7 $9.671 $1.3 643.92%

The Trend in the Analyst Price Target


MDNA's average price target has moved down $2.51 over the prior 44 weeks.

Over the past 48 weeks, MDNA's average upside potential has been 312.97%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-17 2 11.87099 6.92474 9.89487 2.81 252.13%
2021-08-01 2 12.07930 7.04626 10.06448 2.51 300.98%
2021-08-07 2 11.99360 6.99627 9.99307 2.26 342.17%
2021-08-23 2 12.12629 7.07367 10.10924 2.20 359.51%
2021-11-16 4 12.00000 7.00000 10.01800 2.38 320.92%

MDNA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 48 weeks, MDNA's average broker recommendation rating improved by 1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In the context of all US stocks, Medicenna Therapeutics Corp's upside potential (average analyst target price relative to current price) is higher than 390.78% of them.
  • To contextualize these metrics, consider that out of all US stocks, Medicenna Therapeutics Corp's average analyst price target is greater than 34.31% of them.
  • MDNA has a higher number of analysts covering the stock than 338.08% of stocks in the micro market cap category.
  • In the context of stocks in the micro market cap category, Medicenna Therapeutics Corp's variance in analysts' estimates is lower than -188.82% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Medicenna Therapeutics Corp are MBRX, LTRN, and LPTX.

Is MDNA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.778 seconds.